A 1 and A 2A adenosine receptor modulation of α 1-adrenoceptor-mediated contractility in human cultured prostatic stromal cells

British Journal of Pharmacology

Volumn 141, Issue 2, 2004, Pages 302-310

  Preston, A ^a,c   Frydenberg, M ^b   Haynes, J M ^c  

^a RMIT UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

A 1 adenosine receptor; A 2A adenosine receptor; cAMP; Human cultured prostatic stromal cells; pH

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR STIMULATING AGENT; ALPHA 1 ADRENERGIC RECEPTOR; CYCLIC AMP; CYCLOPENTYLADENOSINE; PHENYLEPHRINE; UNCLASSIFIED DRUG; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; XANTHINE DERIVATIVE;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROSTATE EPITHELIUM; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY; REGULATORY MECHANISM; STROMA CELL; AGED; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; MALE; PHYSIOLOGY; PROSTATE;

ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); AGED; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; PROSTATE; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; RECEPTORS, ADRENERGIC, ALPHA-1; STROMAL CELLS; XANTHINES;

EID: 1342322697     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705535     Document Type: Article

References (50)

1. ABEBE, W. & MUSTAFA, S.J. (1998). Al adenosine receptor-mediated Ins(1,4,5)P3 generation in allergic rabbit airway smooth muscle. Am. J. Physiol., 275, L990-L997.
2. BAKER, S.P., SCAMMELLS, P.J. & BELARDINELLI, L. (2000). Differential A(1)-adenosine receptor reserve for inhibition of cyclic AMP accumulation and G-protein activation in DDT(1) MF-2 cells. Br. J. Pharmacol., 130, 1156-1164.
3. COOK, A.L., FRYDENBERG, M. & HAYNES, J.M. (2002). Protein kinase G activation of K(ATP) channels in human-cultured prostatic stromal cells. Cell Signal., 14, 1023-1029.
4. COOPER, J., HILL, S.J. & ALEXANDER, S.P. (1997). An endogenous A2B adenosine receptor coupled to cyclic AMP generation in human embryonic kidney (HEK 293) cells. Br. J. Pharmacol., 122, 546-550.
5. CORDEAUX, Y., BRIDDON, S.J., MEGSON, A.E., MCDONNELL, J., DICKENSON, J.M. & HILL, S.J. (2000). Influence of receptor number on functional responses elicited by agonists acting at the human adenosine A(1) receptor: evidence for signaling pathway-dependent changes in agonist potency and relative intrinsic activity. Mol. Pharmacol., 58, 1075-1084.
6. CORVIN, S., BOSCH, S.T., EDER, I., THURNHER, M., BARTSCH, G. & KLOCKER, H. (1998). Videoimaging of prostatic stromal-cell contraction: an in vitro model for studying drug effects. Prostate, 37, 209-214.
7. DALZIEL, H.H. & WESTFALL, D.P. (1994). Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. Pharmacol. Rev., 46, 449-466.
8. DICKENSON, J.M. & HILL, S.J. (1993). Adenosine A1-receptor stimulated increases in intracellular calcium in the smooth muscle cell line, DDT1MF-2. Br. J. Pharmacol., 108, 85-92.
9. ECKERT, R.E., SCHREIER, U., DRESCHER, P., MADSEN, P.O., DEROUET, H., BECHT, E., STEFFENS, J. & ZIEGLER, M. (1995). Regulation of prostatic smooth muscle contractility by intracellular second messengers: implications for the conservative treatment of benign prostatic hyperplasia. Urol. Int., 54, 6-21.
10. FARMER, S.G., CANNING, B.J. & WILKINS, D.E. (1988). Adenosine receptor-mediated contraction and relaxation of guinea-pig isolated tracheal smooth muscle: effects of adenosine antagonists. Br. J. Pharmacol., 95, 371-378.
11. FERRE, S., TORVINEN, M., ANTONIOU, K., IRENIUS, E., CIVELLI, O., ARENAS, E., FREDHOLM, B.B. & FUXE, K. (1998). Adenosine A1 receptor-mediated modulation of dopamine D1 receptors in stably cotransfected fibroblast cells. J. Biol. Chem., 273, 4718-4724.
12. FORD, W.R. & BROADLEY, K.J. (1999). Effects of adenosine receptor agonists on induction of contractions to phenylephrine of guinea-pig aorta mediated via intra- or extracellular calcium. Gen. Pharmacol., 33, 143-150.
13. FREDHOLM, B.B., AP, I.J., JACOBSON, K.A., KLOTZ, K.N. & LINDEN, J. (2001). International Union of Pharmacology XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev., 53, 527-552.
14. FREDHOLM, B.B., ARSLAN, G., HALLDNER, L., KULL, B., SCHULTE, G. & WASSERMAN, W. (2000). Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch. Pharmacol., 362, 364-374.
15. GERWINS, P. & FREDHOLM, B.B. (1992). Stimulation of adenosine A1 receptors and bradykinin receptors, which act via different G proteins, synergistically raises inositol 1,4,5-trisphosphate and intracellular free calcium in DDTI MF-2 smooth muscle cells. Proc. Natl. Acad. Sci. USA, 89, 7330-7334.
16. GOPALAKRISHNAN, M., WHITEAKER, K.L., MOLINARI, E.J., DAVIS-TABER, R., SCOTT, V.E., SHIEH, C.C., BUCKNER, S.A., MILICIC, I., CAIN, J.C., POSTL, S., SULLIVAN, J.P. & BRIONI, J.D. (1999). Characterization of the ATP-sensitive potassium channels (KATP) expressed in guinea pig bladder smooth muscle cells. J. Pharmacol. Exp. Ther., 289, 551-558.
17. HADJKADDOUR, K., MICHEL, A., LAURENT, F. & BOUCARD, M. (1996). Smooth muscle relaxant activity of A1- and A2-selective adenosine receptor agonists in guinea pig trachea: involvement of potassium channels. Fundam. Clin. Pharmacol., 10, 269-277.
18. HAYNES, J.M. (2000). A(2A) adenosine receptor mediated potassium channel activation in rat epididymal smooth muscle. Br. J. Pharmacol., 130, 685-691.
19. HAYNES, J.M., ALEXANDER, S.P. & HILL, S.J. (1998a). A1 adenosine receptor modulation of electrically evoked contractions in the bisected vas deferens and cauda epididymis of the guinea-pig. Br. J. Pharmacol., 124, 964-970.
20. HAYNES, J.M., ALEXANDER, S.P. & HILL, S.J. (1998b). A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig. Br. J. Pharmacol., 125, 570-576.
21. HAYNES, J.M., FRYDENBERG, M. & MAJEWSKI, H. (2001). Testosterone- and phorbol ester-stimulated proliferation in human cultured prostatic stromal cells. Cell Signal., 13, 703-709.
22. 2+ influx in human cultured prostatic stromal cells. Biochem. Pharmacol., 64, 385-392.
23. HAYNES, J.M., SELBIE, L.A. & HILL, S.J. (1999). Gi-Protein alpha-subunit mRNA antisense oligonucleotide inhibition of Gi-coupled receptor contractile activity in the epididymis of the guinea-pig. Br. J. Pharmacol., 127, 85-90.
24. HIEBLE, J.P., CAINE, M. & ZALAZNIK, E. (1985). In vitro characterization of the alpha-adrenoceptors in human prostate. Eur. J. Pharmacol., 107, 111-117.
25. HOQUE, N., COOK, M.A. & KARMAZYN, M. (2000). Inhibition of alpha(1)-adrenergic-mediated responses in rat ventricular myocytes by adenosine A(1) receptor activation: role of the K(ATP) channel. J. Pharmacol. Exp. Ther., 294, 770-777.
26. 2+ mobilization and activation of extracellular acidification by carbachol in acutely dispersed cells from guinea pig detrusor: Fura 2 fluorometry and microphysiometry using the cytosensor. Life Sci., 65, 1569-1577.
27. JONZON, B., NILSSON, J. & FREDHOLM, B.B. (1985). Adenosine receptor-mediated changes in cyclic AMP production and DNA synthesis in cultured arterial smooth muscle cells. J. Cell Physiol., 124, 451-456.
28. KLOTZ, K.N. (2000). Adenosine receptors and their ligands. Naunyn Schmiedebergs Arch. Pharmacol., 362, 382-391.
29. KOBAYASHI, S., IKEDA, K., MIYATA, K., YAMADA, T. & HONDA, K. (2001). A method for measurement of muscarinic receptor-mediated responses in dissociated single colon longitudinal smooth muscle cells. J. Pharmacol. Toxicol. Methods, 45, 199-205.
30. LEPOR, H., GUP, D.I., BAUMANN, M. & SHAPIRO, E. (1991). Comparison of alpha 1 adrenoceptors in the prostate capsule of men with symptomatic and asymptomatic benign prostatic hyperplasia. Br. J. Urol., 67, 493-498.
31. LEPOR, H., TANG, R., MERETYK, S. & SHAPIRO, E. (1993). Alpha 1 adrenoceptor subtypes in the human prostate. J. Urol., 149, 640-642.
32. MARIAN, T., RUBOVSZKY, B., SZENTMIKLOSI, A.J., TRON, L., BALKAY, L., BOROS, I., GASPAR, R., SZEKELY, A. & KRASZNAI, Z. (2002). A1 and A2 adenosine receptor activation inversely modulates potassium currents and membrane potential in DDT1 MF-2 smooth muscle cells. Jpn. J. Pharmacol., 89, 366-372.
33. MARSHALL, I., BURT, R.P. & CHAPPLE, C.R. (1995). Noradrenaline contractions of human prostate mediated by alpha 1A- (alpha 1c-) adrenoceptor subtype. Br. J. Pharmacol., 115, 781-786.
34. MCCONNELL, H.M., OWICKI, J.C., PARCE, J.W., MILLER, D.L., BAXTER, G.T., WADA, H.G. & PITCHFORD, S. (1992). The cytosensor microphysiometer: biological applications of silicon technology. Science, 257, 1906-1912.
35. NG, S.S., PANG, R.T., CHOW, B.K. & CHENG, C.H. (1999). Real-time evaluation of human secretin receptor activity using cytosensor microphysiometry. J. Cell Biochem., 72, 517-527.
36. ONGINI, E., DIONISOTTI, S., GESSI, S., IRENIUS, E. & FREDHOLM, B.B. (1999). Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors. Naunyn Schmiedebergs Arch. Pharmacol., 359, 7-10.
37. POUCHER, S.M., KEDDIE, J.R., SINGH, P., STOGGALL, S.M., CAULKETT, P.W., JONES, G. & COLL, M.G. (1995). The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist. Br. J. Pharmacol., 115, 1096-1102.
38. PRENTICE, D.J., KELLY, M.D., LEDENT, C. & HOURANI, S.M. (2002). Relaxation of the mouse isolated aorta and carotid artery in response to adenosine analogues in genetically modified mice lacking the adenosine A(2A) receptor. Naunyn Schmiedebergs Arch. Pharmacol., 366, 127-133.
39. PRENTICE, D.J., PAYNE, S.L. & HOURANI, S.M. (1997). Activation of two sites by adenosine receptor agonists to cause relaxation in rat isolated mesenteric artery. Br. J. Pharmacol., 122, 1509-1515.
40. PRESTON, A. & HAYNES, J.M. (2003). Alpha(1)-adrenoceptor effects mediated by protein kinase C alpha in human cultured prostatic stromal cells. Br. J. Pharmacol., 138, 218-224.
41. PRESTON, A., LAU, W.A., PENNEFATHER, J.N. & VENTURA, S. (2000). Effects of adenine nucleosides and nucleotides on neuromuscular transmission to the prostatic stroma of the rat. Br. J. Pharmacol., 131, 1073-1080.
42. RINK, T., TSIEN, R. & POZZAN, T. (1982). Cytoplasmic pH and free Mg2+ in lymphocytes. J. Cell Biol., 95, 189-196.
43. SAWMILLER, D.R., FENTON, R.A. & DOBSON JR, J.G. (1996). Myocardial adenosine A1 and A2 receptor activities during juvenile and adult stages of development. Am. J. Physiol., 271, H235-43.
44. SEDAA, K.O., BJUR, R.A., SHINOZUKA, K. & WESTFALL, D.P. (1990). Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta. J. Pharmacol. Exp. Ther., 252, 1060-1067.
45. SHIM, J.O., SHIN, C.Y., LEE, T.S., YANG, S.J., AN, J.Y., SONG, H.J., KIM, T.H., HUH, I.H. & SOHN, U.D. (2002). Signal transduction mechanism via adenosine A1 receptor in the cat esophageal smooth muscle cells. Cell Signal., 14, 365-372.
46. SHINOZUKA, K., HASHIMOTO, M., MASUMURA, S., BJUR, R.A., WESTFALL, D.P. & HATTORI, K. (1994). In vitro studies of release of adenine nucleotides and adenosine from rat vascular endothelium in response to alpha 1-adrenoceptor stimulation. Br. J. Pharmacol., 113, 1203-1208.
47. 3H]-dipropyl-8- cyclopentylxanthine binding site in rat vas deferens. Clin. Exp. Pharmacol. Physiol., 24, 492-497.
48. TALUKDER, M.A., MORRISON, R.R. & MUSTAFA, S.J. (2002). Comparison of the vascular effects of adenosine in isolated mouse heart and aorta. Am. J. Physiol. Heart Circ. Physiol., 282, H49-57.
49. XIA, Y., FERTEL, R.H. & WOOD, J.D. (1997). Suppression of cAMP formation by adenosine in myenteric ganglia from guinea-pig small intestine. Eur. J. Pharmacol., 320, 95-101.
50. ZHANG, J., HESS, M.W., THURNHER, M., HOBISCH, A., RADMAYR, C., Cronauer, M.V., HITTMAIR, A., CULIG, Z., BARTSCH, G. & KLOCKER, H. (1997). Human prostatic smooth muscle cells in culture: estradiol enhances expression of smooth muscle cell-specific markers. Prostate, 30, 117-129.